(Q31804328)

3 July 2017

title

Selegiline completely restores choline acetyltransferase activity deficits in simian immunodeficiency infection (English)

1 reference

3 July 2017

Koutsilieri E

1

1 reference

3 July 2017

Scheller C

2

1 reference

3 July 2017

Sopper S

3

1 reference

3 July 2017

Götz ME

4

1 reference

3 July 2017

Gerlach M

5

1 reference

3 July 2017

Meulen V

6

1 reference

3 July 2017

Riederer P

7

1 reference

3 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

European Journal of Pharmacology

3 July 2017

published in

1 reference

3 July 2017

volume

411

1 reference

3 July 2017

issue

1-2

1 reference

3 July 2017

page(s)

R1-R2

1 reference

A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders

3 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900874-8

The molecular pharmacology of L-deprenyl

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900874-8

The possible mechanisms of action of (-)deprenyl in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900874-8

Brain choline acetyltransferase reduction in SIV infection. An index of early dementia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900874-8

Update on current models of HIV-related neuronal injury: platelet-activating factor, arachidonic acid and nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900874-8

Cognitive and motor impairments associated with SIV infection in rhesus monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900874-8

L-deprenyl protects mesencephalic dopamine neurons from glutamate receptor-mediated toxicity in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900874-8

Monoamine oxidase-B inhibitors in the treatment of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900874-8

10.1016/S0014-2999(00)00874-8

7 January 2021

Identifiers

DOI

1 reference

3 July 2017

1 reference